Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06311110
Other study ID # #BC-11326 AM04
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date October 30, 2023
Est. completion date June 30, 2024

Study information

Verified date March 2024
Source University Hospital, Ghent
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This cross-sectional case-control study aimed to determine whether there is a significant difference in the prevalence of impaired toilet training, LUTS, and functional bowel problems among children diagnosed with DCD and typically developing children (TDC).


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 84
Est. completion date June 30, 2024
Est. primary completion date February 8, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 5 Years to 8 Years
Eligibility Inclusion Criteria: - Diagnosed with DCD by a multidisciplinary team (DCD case group) - Children with a typical development, grade and gender matched with the DCD case group (TDC control group). Exclusion Criteria: - A DCD-Q score indicative for DCD (TDC control group) - Presence of other developmental disorders, such as ASS, ADHD or intellectual disability (TDC control group)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Vancouver symptom score for dysfunctional elimination symptoms Questionnaire
Vancouver symptom score for dysfunctional elimination syndrome, Dutch version, validated by 't Hoen et al. 2016. The questionnaire is filled in by the parents of the child.
Developmental Coordination Disorder Questionnaire
Validated Developmental Coordination Disorder Questionnaire, Dutch version includes assessment of motor functioning. The questionnaire is filled in by the parents of the child.
Questionnaire concerning impaired toilettraining and comorbities
Unvalidated, complementary questions concerning impaired toilettraining and comorbidities. Questions were based on ICCS standardisation guidelines (Austin et al., 2015). The questionnaire is filled in by the parents of the child.

Locations

Country Name City State
Belgium Ghent University Hospital/Ghent University Ghent East Flanders

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Ghent

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Impaired toilet training Prevalence of impaired toilet training in children with DCD compared to TDC through study completion, 25 minutes
Primary Daytime incontinence Prevalence of daytime incontinence at 5 years old in children with DCD compared to TDC through study completion, 25 minutes
Primary Enuresis Prevalence of enuresis at 5 years old in children with DCD compared to TDC through study completion, 25 minutes
Primary Fecal incontinence Prevalence of fecal incontinence at 4 years old in children with DCD compared to TDC through study completion, 25 minutes
Secondary Toilet training difficulties Prevalence and amount of toilet training difficulties in children with DCD compared to TDC through study completion, 25 minutes
Secondary General bladder and bowel dysfunction Prevalence of LUTS, bowel problems or combined bladder and bowel dysfunction in children with DCD compared to TDC through study completion, 25 minutes
See also
  Status Clinical Trial Phase
Completed NCT04856748 - Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
Completed NCT03623880 - Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders N/A
Enrolling by invitation NCT06317116 - Examining the Relationship Between Core Muscles and Bladder Issues in Children
Completed NCT03625843 - Mindfulness Exercises to Reduce Anxiety and Pain During Urodynamic Testing N/A
Recruiting NCT05814614 - Bladder Complaints in Parkinson's Disease Effectiveness of Pelvic Floor Muscle Exercises and Electrical Stimulation N/A
Recruiting NCT04288427 - 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy N/A
Not yet recruiting NCT06452927 - EEP in Patients With Urodynamically Proven DU/DA N/A
Completed NCT03339609 - Uroflow Measurement With Electromyography (EMG) to Identify Lower Urinary Tract Symptoms (LUTS): Conducted on Healthy Children N/A
Completed NCT02330107 - Auriculotherapy on Lower Urinary Tract Symptoms in Elderly Men N/A
Terminated NCT02003742 - Efficacy and Safety of a Single TRUS-guided Intraprostatic Injection of NX-1207 in Patients With LUTS Due to BPH Phase 3
Terminated NCT01003249 - Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen Phase 4
Completed NCT01078545 - Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS) N/A
Completed NCT02074644 - Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia N/A
Recruiting NCT03802851 - HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer N/A
Active, not recruiting NCT05415748 - Deprescribing Tamsulosin in Older Men Phase 4
Recruiting NCT05702294 - Electronic Urinary Flowmeter to Improve Accuracy of Bladder Diaries . N/A
Enrolling by invitation NCT05537272 - The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transperineal Prostate Biopsy Phase 4
Recruiting NCT05826691 - Benign Prostate Surgery and QOL and Sexual Function
Completed NCT04104100 - Prevalence and Risk Factor of NP in Women With LUTS
Completed NCT04190641 - Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder N/A